In cancer, the expression levels of PRC1 components are often altered, leading to aberrant chromatin states and gene expression patterns. For instance, overexpression of BMI1 has been linked to increased cell proliferation and resistance to apoptosis, which are hallmarks of cancer. Similarly, elevated levels of RING1B have been associated with poor prognosis in various cancers.
